A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma (Q33155566)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma |
scientific article |
Statements
1 reference
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma (English)
1 reference
F Morschhauser
1 reference
J F Seymour
1 reference
H C Kluin-Nelemans
1 reference
A Grigg
1 reference
M Wolf
1 reference
M Pfreundschuh
1 reference
H Tilly
1 reference
J Raemaekers
1 reference
M B van 't Veer
1 reference
N Milpied
1 reference
G Cartron
1 reference
A Pezzutto
1 reference
A Spencer
1 reference
F Reyes
1 reference
M Dreyling
1 reference
28 September 2007
1 reference
1 reference
Identifiers
1 reference